UK Operations: +44(0) 2031961566

End-to-End Clinical Trial Management

From early-stage protocol feasibility to final study report and NDA submission, ASSAY provides synchronized, risk-managed trial delivery.

Comprehensive Scope

Ten Pillars of Our CTM Framework

Every clinical project is supported by a bespoke operational team, robust SOPs, and integrated data visibility.

e-Feasibility Studies

Algorithm-driven site identification, patient prevalence modeling, and realistic recruitment commitment forecasts.

Phase I–IV Execution

Seamless execution across all trial phases, including healthy volunteer PK studies, proof-of-concept, and pivotal Phase III trials.

Data Safety Management

Proactive pharmacovigilance, real-time adverse event processing, and DSMB / IDMC charter execution.

Dedicated Operations Team

Assigned Senior Project Managers and seasoned CRAs with deep local regulatory knowledge and investigator relationships.

Audit & Inspection Readiness

Continuous mock audit drills, TMF completeness checks, and regulatory inspection preparation.

GRAVITY Document Engine

Direct integration with our DIA TMF Reference Model e-TMF and investigator site file repository.

Lifecycle Stages

Detailed Operational Lifecycle

Explore our systematic approach across each stage of clinical trial conduct.

1
Start-Up Capabilities & Study Set-Up
  • Consultation on protocol design from an operational and regulatory perspective.
  • Upfront discussion on anticipated protocol challenges and preventive CAPA strategies.
  • Creation of study-specific worksheets, investigator toolkits, and monitoring manuals.
  • Rapid collection of essential documents and Ethics Committee / IRB submissions.
2
Regulatory Submissions & Country Selection
  • Advisory on optimal country and site selection based on regulatory speed and disease burden.
  • Preparation and review of Clinical Trial Applications (CTA / IND).
  • Direct liaising with Competent Authorities (MHRA, EMA, FDA, CDSCO, etc.).
3
Study Conduct & Risk-Based Monitoring
  • Combination of centralized risk-based monitoring and comprehensive on-site SDV.
  • Real-time issue escalation and protocol deviation management.
  • Investigational Medicinal Product (IMP) tracking and temperature log verification.
4
Close-Out, Archiving & Reporting
  • Final site close-out visits and drug reconciliation/destruction certification.
  • TMF final reconciliation and audit-ready digital handover.
  • Regulatory notifications of trial completion and CSR development support.

Ready to Evaluate Your Study Feasibility?

Contact our clinical operations experts today for protocol feasibility review and timeline benchmarking.

Contact Operations Team